Posterior circulation stroke accounts for one-fifth of all strokes, but despite this, it has been a neglected area. It can present considerable challenges in diagnosis, and there are fewer studies examining optimal treatment compared with anterior circulation stroke. This month's issue of IJS attempts to address this balance. We have a particular focus on posterior circulation stroke with coverage of areas ranging from diagnosis, through acute treatment and thrombectomy, to secondary prevention. This initiative is particularly opportune with the recent announcement of two positive studies of thrombectomy for basilar artery occlusion (BAO).Diagnosis of posterior circulation stroke can be challenging, in part because of substantial overlap in symptoms and signs with ischemia in the anterior circulation, but some clinical signs are highly specific to posterior circulation strokes because of the unique functions and vascular supply of the brainstem. A comprehensive review from Salerno and colleagues describes the clinical and corresponding anatomical features of PC stroke, and highlights specific syndromes. 1 It also covers optimal imaging approaches. It makes for a very useful clinical update.Management of posterior circulation stroke, particularly acute reperfusion therapy and neurointervention procedures for secondary prevention, has received much less attention than similar interventions for the anterior circulation. For example, whether thrombectomy is as effective for BAO as it is for anterior circulation stroke is debated, particularly after the negative BASICS trial. 2 Our second review in this issue provides the latest data on management of posterior circulation stroke, both acute and secondary prevention. 3 It highlights the results from two recent trials of thrombectomy presented in May at the European Stroke Congress 2022, which both showed that thrombectomy was highly effective for BAO. 4 ATTENTION (EndovAscular TreaTmENT for acute basilar artery occlusION), the protocol paper of which is also published in this issue, 5 recruited patients within 0-12 h from the estimated time of stroke onset in China. A total of 340 patients were randomly assigned to thrombectomy or best medical management in a 2:1 ratio. There was a highly significant improvement in the primary endpoint of modified Rankin score 0-3 at 90 days which was achieved in 104/226 (46%) of the endo-